Relationship between TNF- gene promoter polymorphisms and outcomes of hepatitis B virus infections: A meta-analysis

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Xia, Qi ^a   Zhou, LinFu ^b   Liu, Dongcheng ^a   Chen, Zhi ^a   Chen, Feng ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; THREONINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHRONIC DISEASE; ETHNIC DIFFERENCE; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS B VIRUS; HETEROZYGOTE; HUMAN; INFECTION RISK; MOLECULAR PHYLOGENY; PROGNOSIS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC HETEROGENEITY; GENETICS; GENOTYPE; META ANALYSIS; PHYSIOLOGY; PUBLISHING; RISK; RISK FACTOR; TREATMENT OUTCOME;

HEPATITIS B VIRUS;

GENETIC HETEROGENEITY; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PUBLICATION BIAS; RISK FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955897241     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019606     Document Type: Article

References (32)

1. Chisari FV, Ferrari C, (1995) Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13: 29-60.
2. Wang FS, (2003) Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol 9: 641-644.
3. Tokushige K, Yamaguchi N, Ikeda I, Hashimoto E, Yamauchi K, et al. (2000) Significance of soluble TNF receptor-I in acute-type fulminant hepatitis. Am J Gastroenterol 95: 2040-2046.
4. Bozkaya H, Bozdayi M, Turkyilmaz R, Sarioglu M, Cetinkaya H, et al. (2000) Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease. Hepatogastroenterology 47: 1675-1679.
5. Kamali-Sarvestani E, Merat A, Talei AR, (2005) Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-alpha and TNF-beta) and gamma interferon (IFN-gamma) among Iranian women with breast cancer. Cancer Lett 223: 113-119.
6. Chen DQ, Zeng Y, Zhou J, Yang L, Jiang S, et al. (2010) Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population. J Med Virol 82: 371-378.
7. Kim YJ, Lee HS, Yoon JH, Kim CY, Park MH, et al. (2003) Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet 12: 2541-2546.
8. Niro GA, Fontana R, Gioffreda D, Valvano MR, Lacobellis A, et al. (2005) Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection. Liver Int 25: 1175-1181.
9. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenefelde KH, et al. (1998) A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 111: 579-582.
10. Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, et al. (2006) Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. J Gastroenterol Hepatol 21: 1163-1169.
11. Ribeiro CS, Visentainer JE, Moliterno RA, (2007) Association of cytokine genetic polymorphism with hepatitis B infection evolution in adult patients. Mem Inst Oswaldo Cruz 102: 435-440.
12. Somi MH, Najafi L, Noori BN, Alizadeh AH, Aghah MR, et al. (2006) Tumor necrosis factor-alpha gene promoter polymorphism in Iranian patients with chronic hepatitis B. Indian J Gastroenterol 25: 14-15.
13. Lau J, Ioannidis JP, Schmid CH, (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826.
14. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
15. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
16. Cheong JYC, Hahm S.W., Yoon SK K.B., Lee JH, Park CS, Lee JE, Kim JH, (2005) Association between chronic hepatitis B virus infection and tumor necrosis factor-alpha gene promoter polymorphisms. Korean J Med 68: 619-627.
17. Li HQ, Li Z, Liu Y, Li JH, Dong JQ, et al. (2005) Association of polymorphism of tumor necrosis factor-alpha gene promoter region with outcome of hepatitis B virus infection. World J Gastroenterol 11: 5213-5217.
18. Li HQ, Li Z, Liu Y, Li JH, Dong JQ, et al. (2006) Association of-238G/A and-857C/T polymorphisms of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection. Biomed Environ Sci 19: 133-136.
19. Kim GH, Lee DH, Kim HW, Cheong JY, Seo SB, et al. (2005) Relationships between the expressions of CDX1 and CDX2 mRNA and clinicopathologic features in colorectal cancers. Korean J Intern Med 20: 317-324.
20. Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N, (2007) Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat 14: 841-848.
21. Wan PQ, Wu JZ, (2010) Association of TNF-857 C/T and-863 C/A Polymorphisms Gene Promoter Region with Outcomes of Hepatitis B Virus Infection Guangxi Medical Journal 32: 381-385.
22. Xing PX, Zou MJ, Xing QT, Wang HC, Wang, YS, (2007) Relationship between proinflammatory cytokine gene polymorphisms and diseases of HBV infection. Journal or Shandong university(health sciences) 45: 1229-1233.
23. Zhang PA, Li Yan, Xiang PX, Wu JM, (2004) Association of TNF-a gene promoter polymorphisms with outcome of hepatitis B virus infection. World Chin J Digestol 12: 2086-2090.
24. Xing PX, (2007) Relationship between proinflammatory cytokine gene polymorphisms and diseases o fHBV infection. JOURNAL OF SHANDONG UNIVERSITY(HEALTH SCIENCES) 45: 1229-1233.
25. Koziel MJ, (1999) Cytokines in viral hepatitis. Semin Liver Dis 19: 157-169.
26. Puro R, Schneider RJ, (2007) Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA. J Virol 81: 7351-7362.
27. Bradham CA, Plumpe J, Manns MP, Brenner DA, Trautwein C, (1998) Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol 275: G387-392.
28. Zheng MH, Qiu LX, Xin YN, Pan HF, Shi KQ, et al. (2010) Tumor necrosis factor-alpha-308A allele may have a protective effect for chronic hepatitis B virus infection in Mongoloid populations. Int J Infect Dis 14: e580-585.
29. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW, (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94: 3195-3199.
30. Abraham LJ, Kroeger KM, (1999) Impact of the-308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66: 562-566.
31. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, et al. (1999) A common functional polymorphism (C-->A substitution at position-863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 8: 1443-1449.
32. Lu LP, Li XW, Liu Y, Sun GC, Wang XP, et al. (2004) Association of-238G/A polymorphism of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection in Chinese Han population. World J Gastroenterol 10: 1810-1814.